Thu , December 2, 2021
SpanishEnglish
Volcano
Home / Cannabis News / Curaleaf Is Acquiring Dispensaries in AZ, NV and UT

Curaleaf Is Acquiring Dispensaries in AZ, NV and UT

Reef Dispensaries

Curaleaf, a leading international provider of consumer products in cannabis, entered into a definitive agreement to acquire Tryke Companies (dba as Reef Dispensaries), a privately held vertically integrated, multi-state cannabis operator, in a cash and stock transaction valued at approximately US$286 million. The transaction is expected to close in the second half of 2022, subject to customary approvals and conditions.

Under the terms of the agreement, Curaleaf will pay¬†US$40 million¬†in cash at closing, with a remaining¬†US$75 million¬†in cash to be paid in equal installments on the first, second and third anniversaries of the closing. The stock portion of the transaction, which consists of 17 million subordinate voting shares of Curaleaf (“Curaleaf Shares”), will also be paid in three equal installments on the first, second and third anniversaries of the closing. An incremental earnout of up to 1 million Curaleaf Shares may be paid in 2023 based on the business exceeding certain EBITDA targets for the year 2022.

Founded in¬†Arizona in 2014, Tryke has focused on growing and producing the finest and most consistent marijuana products on the market. The company helped pioneer Nevada’s legal medical and recreational cannabis markets from its inception in 2015, and continues to lead the industry in Utah¬†where it has worked since 2019 to help establish the state’s medical cannabis program. Tryke has refined processes to craft an ever-evolving selection of products and brands at multiple price points. The company’s dispensaries have served more than 7.6 million customers, offering a wide variety of in-house and third-party flower, concentrates, vape cartridges, edibles, topicals and CBD products. Upon closing, Curaleaf will assume ownership of Tryke’s extensive portfolio of processing licenses and expects to significantly expand its cultivation capacity from 30,000 square feet to over 80,000 square feet over the next three years.

“This is a tremendous opportunity for Tryke and, as a combined entity, we will continue to deliver significant value for our consumers and retailers in Arizona,¬†Nevada¬†and¬†Utah,” said¬†Adam Ryan, Chief Executive Officer of Tryke Companies. “As a part of Curaleaf’s growing network of dispensaries, Tryke is excited to bring its full suite of multi-price point products to an expanded base of consumers across the country. We are excited to join forces with the industry leader at such a pivotal moment in¬†the United States’¬†legalization efforts. We share Curaleaf’s optimism for the future and are excited to become investors alongside the Company’s talented leadership team.”

Strategic and Financial Benefits

  • Enhances Curaleaf’s operations in¬†Arizona,¬†Nevada¬†and¬†Utah:¬†Tryke currently owns and operates six heavily trafficked dispensaries under the Reef brand, with two retail stores in¬†Arizona¬†and four in¬†Nevada, including the¬†Phoenix¬†metropolitan area,¬†Las Vegas¬†strip and¬†North Las Vegas. The company’s products are sold in over 50 additional locations across its footprint.
  • Enriches Curaleaf’s product offerings: Tryke currently offers a wide variety of in-house and third-party flower, concentrates, vape cartridges, edibles, topicals and CBD products at a range of price points. Tryke’s product portfolio is highly complementary to Curaleaf’s, allowing the Company to offer consumers and retailers in¬†Arizona,¬†Nevada¬†and¬†Utah¬†an even broader selection of premium cannabis products.
  • Improves Curaleaf’s margins and free cash flow generation: Tryke has a strong financial profile, with a history of delivering significant revenue growth and compelling EBITDA margins in excess of 35%. Tryke is expected to record nearly¬†US$110 million¬†in full year 2021 revenue. Curaleaf expects the acquisition will be immediately accretive to the Company’s EBITDA margins and free cash flow generation.

The closing of the transaction is expected to occur in the second half of 2022 subject to customary closing conditions, including the receipt of approval from the applicable state regulators, including the Nevada Cannabis Compliance Board.

 



Arizona Cannabis News and Info


AZ Cannabis Updates